Bli medlem
Bli medlem

Du är här

2016-05-09

Active Ownership Capital proposes to the AGM of STADA Arzneimittel AG the replacement of five Supervisory Board members and the abolition of transfer restrictio

Active Ownership Capital proposes to the AGM of STADA Arzneimittel AG the
replacement of five Supervisory Board members and the abolition of transfer
restrictions for registered shares

DGAP-Media / 09.05.2016 / 15:57

- Active Ownership Capital is confident that STADA Arzneimittel AG is a
uniquely attractive business and anticipates significant potential to
increase value

- Supervisory Board of STADA Arzneimittel AG to be strengthened by new
independent members with broad and relevant experience

- Proposal for reclassification of registered shares with restricted
transferability to registered shares

Luxembourg/Bad Vilbel, 09. May 2016 - Active Ownership Capital, an
independent, partner-managed investment company, today announced that it
has submitted a supplementary motion for the agenda of the Annual General
Meeting of STADA Arzneimittel AG (ISIN DE0007251803) on June 9, 2016.

Active Ownership Capital proposes to the Annual General Meeting the
replacement of five out of nine Supervisory Board members. The candidates
to be appointed include four independent nominees and one representative of
Active Ownership Capital, to which more than 5% of the STADA shares are
attributed to. The proposed candidates have confirmed their willingness to
join the supervisory board of STADA Arzneimittel AG in case of their
election.

- Julia Barth (born 1972) - Legal Counsel GE Healthcare and former General
Counsel Sandoz; legal expert in the pharmaceutical area as well as in
patent law

- Prof. Dr. Norbert Klusen (born 1947) - CEO of Techniker Krankenkasse
until 2012; Member of the Expert Council of the German Ministry of Health
for the innovation fund; expert for the healthcare and the pharmaceutical
industry

- Klaus-Joachim Krauth (born 1961) - Former CFO of HEXAL and Athos; expert
for the healthcare industry and finance; extensive experience in generics
and branded products

- Dr. Ulrich Wandschneider (born 1961) - CEO of Asklepios Kliniken until
April 2016; former Director of Healthcare Consulting at Arthur Andersen;
expert on tax law and healthcare management

- Klaus Röhrig (born 1977) - Founding Partner Active Ownership Capital;
extensive investment, value creation and corporate governance experience

According to the proposal put forward by Active Ownership Capital, the
following members should be dismissed from the Supervisory Board effective
from the close of the Annual General Meeting: Dr. Martin Abend (member of
the Supervisory Board since 2003, born 1963, profession: lawyer), Dr.
Eckhard Brüggemann (member of the Supervisory Board since 1997, born 1940,
profession: medical doctor), Dr. K.F. Arnold Hertzsch (member of the
Supervisory Board since 1993, born 1953, profession: pharmacist), Dieter
Koch (member of the Supervisory Board since 1983, born 1936, profession:
pharmacist), Constantin Meyer (member of the Supervisory Board since 2003,
born 1942, profession: pharmacist).

Active Ownership Capital has issued the following statement in this regard:

"Shareholders rights and obligations include making decisions with regard
to the composition of the Supervisory Board of their company. STADA has
evolved from a generics manufacturer operating in Germany, which primarily
marketed its products to German pharmacies, to a global pharmaceutical
company with an international client base without adapting the competencies
of its Supervisory Board accordingly. The goal of our supplementary motion
is to renew the Supervisory Board of STADA and strengthen it with
internationally renowned pharmaceutical and healthcare industry experts as
well as experts for management, corporate governance, finance and law.
Active Ownership Capital firmly believes that the proposed candidates for
the Supervisory Board are uniquely qualified to meet the challenges of
STADA today and in the future. In our view, STADA has a high value creation
potential. A strengthened Supervisory Board is a first major step to
developing the company further together with the management."

Moreover, Active Ownership Capital proposes the reclassification of
registered shares with restricted transferability to registered shares. The
introduction of registered shares with restricted transferability had
historic reasons, which no longer exist since 1993. Hence, Active Ownership
Capital considers the limitation of rights of shareholders by management as
outdated and inappropriate.

Further information, detailed resumes of the proposed candidates and a
presentation on the supplementary motion of Active Ownership Capital are
available on the following website: www.saz-governance.de

Shareholders of STADA Arzneimittel AG who wish to support the proposals of
Active Ownership Capital, can grant voting proxy rights for the Annual
General Meeting of STADA Arzneimittel AG on June 9, 2016 at no charge. A
corresponding form will be available as of May 16 2016 at the website
www.saz-governance.de

# # #

About Active Ownership Capital
Active Ownership Capital is an independent, partner-managed investment
company which acquires significant minority stakes in publicly listed,
undervalued small- and mid-size companies in German speaking countries
(Germany, Switzerland, Austria) and the Nordics (Sweden, Finland, Denmark,
Norway). Active Ownership Capital follows an active ownership approach and
fosters value creation through operational, strategic and structural
improvements.

For us, active ownership means that we act as the company's partner and
support it long-term. Together with management, we define value-enhancing
strategies and measures and are ready to support their implementation as
supervisory board members and advisors. As equity investors we add
long-term oriented entrepreneurial thinking to publicly listed companies.
Our investor base consists of European family offices and selected
institutional investors.

PRESS CONTACT

Charles Barker Corporate Communications GmbH
KORNELIA SPODZIEJA
kornelia.spodzieja@charlesbarker.de
Tel: +49 69 79409040
Mobile: +49 172 622 7007

TOBIAS EBERLE
tobias.eberle@charlesbarker.de
Tel: +49 69 79409024
Mobile: +49 173 520 4436

End of Media Release

---------------------------------------------------------------------------

Issuer: Active Ownership Capital S.à r.l.
Key word(s): Finance

09.05.2016 Dissemination of a Press Release, transmitted by DGAP - a service
of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

461625 09.05.2016

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.